Best in Biotech 4 Nov 2022Get to know 15 of the best biotech companies in Paris Paris may attract tourist masses, but it also attracts a lot of biotech enthusiasts. In this guide, we explore 15… November 4, 2022 - 11 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
News and Trends 22 Oct 2021Gene-Edited T Cell Therapy Players Battle Safety Doubts Confidence in gene-edited T cell therapies from donor cells has faltered as Allogene Therapeutics paused all clinical development following the… October 22, 2021 - 5 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
In Depth 11 Oct 2021A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology CAR-T therapy has been hailed as a cure for cancer, but what really is this ‘miraculous technology’ and what can… October 11, 2021 - 10 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 23 Feb 2021European Cancer Deals Increasingly Focus on Natural Killer Cells Natural killer cells are becoming a hot topic in the booming cancer cell therapy scene, with the field’s latest big… February 23, 2021 - 6 minutesmins - By Kostas Vavitsas Share WhatsApp Twitter Linkedin Email
News and Trends 17 Dec 2020Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American Society of Hematology (ASH) displayed… December 17, 2020 - 6 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
News and Trends 14 Nov 2019Cellectis’ Off-the-Shelf CAR T-Cell Therapy Shows Solid Tumor Potential An off-the-shelf, gene edited CAR T-cell therapy, developed by the French biotech Cellectis, could be used to tackle solid tumors,… November 14, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 13 Jun 2018French Biotech Develops a New Generation of Safer CAR-T Cells Cellectis is developing a new type of chimeric antigen receptor that could improve the production and safety of CAR-T cell… June 13, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 11 Apr 2018French CAR-T Developer Raises $164M Despite a Challenging Road Cellectis has raised $164M (€132M) in a follow-on offering to further develop its CAR-T technology in clinical trials, despite having mixed… April 11, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
In Depth 13 Mar 2018The Most Important Battle in Gene Editing: CRISPR versus TALEN Despite all the hype, CRISPR is still not in the clinic as a standalone therapy or part of another. So… March 13, 2018 - 6 minutesmins - By Editorial Team Share WhatsApp Twitter Linkedin Email
News and Trends 16 Feb 2018French Biotech Gets a CRISPR Patent for CAR-T Research Update (16/02/2018): On top of the European patent it got last July, Cellectis now also has two US patents to… February 16, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 23 Jan 2018Another Huge Acquisition Sees CAR-T Stocks Jump – Except for Celyad Most CAR-T stocks rose on the news that Big Biotech Celgene has plans to acquire Juno: Cellectis rides the wave… January 23, 2018 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
In Depth 17 Jan 2018An Update on What’s New in the French Biotech Industry Here's a closer look at the French biotech ecosystem in 2017, which remains one the leading industries in Europe along… January 17, 2018 - 4 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Best in Biotech 27 Dec 2017The Biggest Biotech News of 2017: What Happened This Year? Still catching up on news? We've picked out the most exciting things that happened besides clinical results and finance. Here's… December 27, 2017 - 3 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 13 Dec 2017Off-the-Shelf CAR-T Cells Struggle to Improve Cancer Treatment Data presented at ASH 2017 shows that Servier and Pfizer's UCART19, an allogeneic CAR-T therapy originally developed by Cellectis, might… December 13, 2017 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 13 Dec 2017How Biotech Could Change Your Christmas Dinner Turkey, roast potatoes, gravy, pigs in blankets... For me, food is an essential part of Christmas. But, biotechs are working… December 13, 2017 - 6 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 29 Aug 2017Gilead’s €10Bn Buyout of Kite Pharma Shakes European CAR-T Stocks European CAR-T stocks have jumped following Gilead’s announcement that it will acquire Kite Pharma, Novartis’ main competitor to launch the… August 29, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jun 2017UPDATE: The First Off-the-Shelf CAR-T Cancer Therapy has Entered the Clinic Update (28/06/2017): Cellectis has announced the first administration of UCART123 in its Phase I trial in Acute Myeloid Leukemia. Update… June 28, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 13 Jun 2017Will Gene Editing Bypass the GMO Struggle or Worsen Public Distrust? In the US, the first CRISPR-edited crops were able to bypass GMO regulations, but Europe's plant scientists are still awaiting… June 13, 2017 - 6 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
Interview 20 Apr 2017Which EU Immuno-Oncology Company are you Cheering for? Immuno-oncology represents a huge breakthrough towards the search for a cancer cure. Biotechs all around Europe are developing innovative ways… April 20, 2017 - 1 minutemin - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 6 Apr 2017How is Biotech Transforming Pharma’s R&D Model? Since the early 2000s, pharma has undergone a major reorganization. What roles do strategic alliances and acquisitions play in this… April 6, 2017 - 4 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email